<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD010431-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD010431-sec-0015"></div> <div class="table" id="CD010431-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings for the main comparison.</span>Â <span class="table-title">Microâinvasive versus nonâinvasive treatments for managing dental decay in primary and permanent teeth</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Microâinvasive versus nonâinvasive treatments for managing dental decay in primary and permanent teeth</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population</b>: people with dental decay on proximal surfaces of primary and permanent teeth<br><b>Settings</b>: secondary care setting<br><b>Intervention</b>: different microâinvasive methods (e.g. resin infiltration, resin sealant, sealant patch and glass ionomer) </p> <p><b>Comparison</b>: nonâinvasive treatments (e.g. fluoride varnish, advice to floss) </p> <p><b>Radiographic followâup period</b>: 6 months to 3 years </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Odds Ratio<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>â of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with control</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with Sealing</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>Caries progression measured by DSR &gt; pairwise &gt; visual scoring</p> <p>(12 months to 36 months followâup)</p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Study population</p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>OR 0.24<br> (0.14 to 0.41) </p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>602 (7 RCTs)</p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>ââââ<br><b>Moderate</b><sup>a,b,c</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>The quality of evidence for caries progression measured by scoring (12 to 30 months), including 468 participants (5 RCTs), OR 0.27 (95% CI 0.17 to 0.44), was <b>moderate</b><sup>a,b,c</sup>. </p> <p>The quality of evidence for caries progression measured by pairwise (18 to 36 months), including 330 participants (4 RCTs), OR 0.31 (95% CI 0.18 to 0.53), was <b>moderate</b><sup>a,b,c</sup>. </p> <p>The quality of evidence for caries progression measured by digital substraction radiography (12 months to 18 months), including 270 participants (3 RCTs), OR 0.18 (95% CI 0.06 to 0.50), was <b>moderate</b><sup>a,b,c</sup>. </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>547 per 1000</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>284 per 1000<br> (230 to 361) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Moderate</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>649 per 1000</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>337 per 1000<br> (272 to 428) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Change in decayed, missing and filled (DMF/dmf) figures at surface, tooth and whole mouth level. </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>â</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>â</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>â</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No studies reported on caries measured as change in decayed, missing and filled (DMF/dmf) figures at surface, tooth or whole mouth level </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><b>CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>OR:</b> odds ratio. </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b> <br><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate quality:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br><b>Low quality:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br><b>Very low quality:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>One or more studies lacked sufficient blinding of participants, personnel or both. Downgraded one level.<br><sup>b</sup>Low number of events. Downgraded one level.<br><sup>c</sup>OR &lt; 0.5. Upgraded one level. </p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
